ID   KDM1A_HUMAN             Reviewed;         852 AA.
AC   O60341; A8MWP9; Q5TH94; Q5TH95; Q86VT7; Q8IXK4; Q8NDP6; Q8TAZ3; Q96AW4;
DT   16-AUG-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2004, sequence version 2.
DT   28-JUN-2023, entry version 222.
DE   RecName: Full=Lysine-specific histone demethylase 1A {ECO:0000305};
DE            EC=1.14.99.66 {ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342};
DE   AltName: Full=BRAF35-HDAC complex protein BHC110;
DE   AltName: Full=Flavin-containing amine oxidase domain-containing protein 2;
DE   AltName: Full=[histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A;
GN   Name=KDM1A {ECO:0000312|HGNC:HGNC:29079};
GN   Synonyms=AOF2, KDM1, KIAA0601, LSD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9628581; DOI=10.1093/dnares/5.1.31;
RA   Nagase T., Ishikawa K., Miyajima N., Tanaka A., Kotani H., Nomura N.,
RA   Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. IX. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:31-39(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 245-852 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE, INTERACTION WITH A HISTONE DEACETYLASE-CONTAINING
RP   COMPLEX, AND FUNCTION.
RX   PubMed=12032298; DOI=10.1073/pnas.112008599;
RA   Hakimi M.-A., Bochar D.A., Chenoweth J., Lane W.S., Mandel G.,
RA   Shiekhattar R.;
RT   "A core-BRAF35 complex containing histone deacetylase mediates repression
RT   of neuronal-specific genes.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7420-7425(2002).
RN   [6]
RP   INTERACTION WITH THE HDAC1 COMPLEX, IDENTIFICATION BY MASS SPECTROMETRY,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=11102443; DOI=10.1074/jbc.m007372200;
RA   Humphrey G.W., Wang Y., Russanova V.R., Hirai T., Qin J., Nakatani Y.,
RA   Howard B.H.;
RT   "Stable histone deacetylase complexes distinguished by the presence of SANT
RT   domain proteins CoREST/kiaa0071 and Mta-L1.";
RL   J. Biol. Chem. 276:6817-6824(2001).
RN   [7]
RP   INTERACTION WITH A HISTONE DEACETYLASE-CONTAINING COMPLEX, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=12493763; DOI=10.1074/jbc.m208992200;
RA   Hakimi M.-A., Dong Y., Lane W.S., Speicher D.W., Shiekhattar R.;
RT   "A candidate X-linked mental retardation gene is a component of a new
RT   family of histone deacetylase-containing complexes.";
RL   J. Biol. Chem. 278:7234-7239(2003).
RN   [8]
RP   CATALYTIC ACTIVITY, FUNCTION, AND COFACTOR.
RX   PubMed=15620353; DOI=10.1016/j.cell.2004.12.012;
RA   Shi Y.-J., Lan F., Matson C., Mulligan P., Whetstine J.R., Cole P.A.,
RA   Casero R.A., Shi Y.;
RT   "Histone demethylation mediated by the nuclear amine oxidase homolog
RT   LSD1.";
RL   Cell 119:941-953(2004).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, AND COFACTOR.
RX   PubMed=15811342; DOI=10.1016/j.febslet.2005.03.015;
RA   Forneris F., Binda C., Vanoni M.A., Mattevi A., Battaglioli E.;
RT   "Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative
RT   process.";
RL   FEBS Lett. 579:2203-2207(2005).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH RCOR1 AND PHF21A.
RX   PubMed=16140033; DOI=10.1016/j.molcel.2005.08.027;
RA   Shi Y.-J., Matson C., Lan F., Iwase S., Baba T., Shi Y.;
RT   "Regulation of LSD1 histone demethylase activity by its associated
RT   factors.";
RL   Mol. Cell 19:857-864(2005).
RN   [11]
RP   FUNCTION, INTERACTION WITH RCOR1, AND MUTAGENESIS OF LYS-661.
RX   PubMed=16079794; DOI=10.1038/nature04021;
RA   Lee M.G., Wynder C., Cooch N., Shiekhattar R.;
RT   "An essential role for CoREST in nucleosomal histone 3 lysine 4
RT   demethylation.";
RL   Nature 437:432-435(2005).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH
RP   AR.
RX   PubMed=16079795; DOI=10.1038/nature04020;
RA   Metzger E., Wissmann M., Yin N., Mueller J.M., Schneider R.,
RA   Peters A.H.F.M., Guenther T., Buettner R., Schuele R.;
RT   "LSD1 demethylates repressive histone marks to promote androgen-receptor-
RT   dependent transcription.";
RL   Nature 437:436-439(2005).
RN   [13]
RP   FUNCTION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16223729; DOI=10.1074/jbc.m509549200;
RA   Forneris F., Binda C., Vanoni M.A., Battaglioli E., Mattevi A.;
RT   "Human histone demethylase LSD1 reads the histone code.";
RL   J. Biol. Chem. 280:41360-41365(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   FUNCTION.
RX   PubMed=17805299; DOI=10.1038/nature06092;
RA   Huang J., Sengupta R., Espejo A.B., Lee M.G., Dorsey J.A., Richter M.,
RA   Opravil S., Shiekhattar R., Bedford M.T., Jenuwein T., Berger S.L.;
RT   "p53 is regulated by the lysine demethylase LSD1.";
RL   Nature 449:105-108(2007).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-59; THR-104; SER-126;
RP   SER-131; SER-166 AND SER-849, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-104; SER-131 AND SER-137, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   FUNCTION, INTERACTION WITH SNAI1 AND RCOR1, IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=20389281; DOI=10.1038/emboj.2010.63;
RA   Lin Y., Wu Y., Li J., Dong C., Ye X., Chi Y.I., Evers B.M., Zhou B.P.;
RT   "The SNAG domain of Snail1 functions as a molecular hook for recruiting
RT   lysine-specific demethylase 1.";
RL   EMBO J. 29:1803-1816(2010).
RN   [23]
RP   RETRACTED PAPER.
RX   PubMed=19880879; DOI=10.1074/jbc.m109.065862;
RA   Lee S.W., Cho Y.S., Na J.M., Park U.H., Kang M., Kim E.J., Um S.J.;
RT   "ASXL1 represses retinoic acid receptor-mediated transcription through
RT   associating with HP1 and LSD1.";
RL   J. Biol. Chem. 285:18-29(2010).
RN   [24]
RP   RETRACTION NOTICE OF PUBMED:19880879 NOTICE FOR PUBMED:19880879.
RX   PubMed=25750265; DOI=10.1074/jbc.a109.065862;
RA   Lee S.W., Cho Y.S., Na J.M., Park U.H., Kang M., Kim E.J., Um S.J.;
RT   "Retraction: 'ASXL1 represses retinoic acid receptor-mediated transcription
RT   through associating with HP1 and LSD1'.";
RL   J. Biol. Chem. 290:6008-6008(2015).
RN   [25]
RP   FUNCTION.
RX   PubMed=20228790; DOI=10.1038/nature08839;
RA   Metzger E., Imhof A., Patel D., Kahl P., Hoffmeyer K., Friedrichs N.,
RA   Muller J.M., Greschik H., Kirfel J., Ji S., Kunowska N.,
RA   Beisenherz-Huss C., Gunther T., Buettner R., Schule R.;
RT   "Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at
RT   histone H3K4.";
RL   Nature 464:792-796(2010).
RN   [26]
RP   FUNCTION, AND INTERACTION WITH SNAI.
RX   PubMed=20562920; DOI=10.1038/onc.2010.234;
RA   Lin T., Ponn A., Hu X., Law B.K., Lu J.;
RT   "Requirement of the histone demethylase LSD1 in Snai1-mediated
RT   transcriptional repression during epithelial-mesenchymal transition.";
RL   Oncogene 29:4896-4904(2010).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-137; SER-166 AND
RP   SER-849, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-137 AND SER-166, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131; SER-137; SER-166 AND
RP   SER-611, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-126; SER-131; TYR-135 AND
RP   SER-137, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [32]
RP   INTERACTION WITH JADE2, INDUCTION, UBIQUITINATION, AND MUTAGENESIS OF
RP   LYS-503.
RX   PubMed=25018020; DOI=10.1016/j.molcel.2014.06.006;
RA   Han X., Gui B., Xiong C., Zhao L., Liang J., Sun L., Yang X., Yu W., Si W.,
RA   Yan R., Yi X., Zhang D., Li W., Li L., Yang J., Wang Y., Sun Y.E.,
RA   Zhang D., Meng A., Shang Y.;
RT   "Destabilizing LSD1 by Jade-2 promotes neurogenesis: an antibraking system
RT   in neural development.";
RL   Mol. Cell 55:482-494(2014).
RN   [33]
RP   INTERACTION WITH ZMYND8, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=25593309; DOI=10.1101/gad.252189.114;
RA   Gong F., Chiu L.Y., Cox B., Aymard F., Clouaire T., Leung J.W.,
RA   Cammarata M., Perez M., Agarwal P., Brodbelt J.S., Legube G., Miller K.M.;
RT   "Screen identifies bromodomain protein ZMYND8 in chromatin recognition of
RT   transcription-associated DNA damage that promotes homologous
RT   recombination.";
RL   Genes Dev. 29:197-211(2015).
RN   [34]
RP   INTERACTION WITH RBPJ AND L3MBTL3.
RX   PubMed=29030483; DOI=10.15252/embj.201796525;
RA   Xu T., Park S.S., Giaimo B.D., Hall D., Ferrante F., Ho D.M., Hori K.,
RA   Anhezini L., Ertl I., Bartkuhn M., Zhang H., Milon E., Ha K., Conlon K.P.,
RA   Kuick R., Govindarajoo B., Zhang Y., Sun Y., Dou Y., Basrur V.,
RA   Elenitoba-Johnson K.S., Nesvizhskii A.I., Ceron J., Lee C.Y., Borggrefe T.,
RA   Kovall R.A., Rual J.F.;
RT   "RBPJ/CBF1 interacts with L3MBTL3/MBT1 to promote repression of Notch
RT   signaling via histone demethylase KDM1A/LSD1.";
RL   EMBO J. 36:3232-3249(2017).
RN   [35]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-442 AND LYS-469, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [36]
RP   FUNCTION.
RX   PubMed=29358331; DOI=10.1074/jbc.ra117.000342;
RA   Zhang C., Hoang N., Leng F., Saxena L., Lee L., Alejo S., Qi D., Khal A.,
RA   Sun H., Lu F., Zhang H.;
RT   "LSD1 demethylase and the methyl-binding protein PHF20L1 prevent SET7
RT   methyltransferase-dependent proteolysis of the stem-cell protein SOX2.";
RL   J. Biol. Chem. 293:3663-3674(2018).
RN   [37]
RP   FUNCTION.
RX   PubMed=29691401; DOI=10.1038/s41467-018-04019-9;
RA   Leng F., Yu J., Zhang C., Alejo S., Hoang N., Sun H., Lu F., Zhang H.;
RT   "Methylated DNMT1 and E2F1 are targeted for proteolysis by L3MBTL3 and
RT   CRL4-DCAF5 ubiquitin ligase.";
RL   Nat. Commun. 9:1641-1641(2018).
RN   [38]
RP   INTERACTION WITH SAMD1, AND SUBCELLULAR LOCATION.
RX   PubMed=33980486; DOI=10.1126/sciadv.abf2229;
RA   Stielow B., Zhou Y., Cao Y., Simon C., Pogoda H.M., Jiang J., Ren Y.,
RA   Phanor S.K., Rohner I., Nist A., Stiewe T., Hammerschmidt M., Shi Y.,
RA   Bulyk M.L., Wang Z., Liefke R.;
RT   "The SAM domain-containing protein 1 (SAMD1) acts as a repressive chromatin
RT   regulator at unmethylated CpG islands.";
RL   Sci. Adv. 7:0-0(2021).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.57 ANGSTROMS) OF 171-836 IN COMPLEX WITH FAD AND
RP   RCOR1.
RX   PubMed=16885027; DOI=10.1016/j.molcel.2006.07.012;
RA   Yang M., Gocke C.B., Luo X., Borek D., Tomchick D.R., Machius M.,
RA   Otwinowski Z., Yu H.;
RT   "Structural basis for CoREST-dependent demethylation of nucleosomes by the
RT   human LSD1 histone demethylase.";
RL   Mol. Cell 23:377-387(2006).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 172-835 IN COMPLEX WITH FAD,
RP   FUNCTION, COFACTOR, AND MUTAGENESIS OF ASN-535; HIS-564 AND TYR-761.
RX   PubMed=16956976; DOI=10.1073/pnas.0606381103;
RA   Chen Y., Yang Y., Wang F., Wan K., Yamane K., Zhang Y., Lei M.;
RT   "Crystal structure of human histone lysine-specific demethylase 1 (LSD1).";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:13956-13961(2006).
RN   [41]
RP   STRUCTURE BY NMR OF 166-285, AND DOMAIN.
RX   PubMed=16531230; DOI=10.1016/j.str.2005.12.004;
RA   Tochio N., Umehara T., Koshiba S., Inoue M., Yabuki T., Aoki M., Seki E.,
RA   Watanabe S., Tomo Y., Hanada M., Ikari M., Sato M., Terada T., Nagase T.,
RA   Ohara O., Shirouzu M., Tanaka A., Kigawa T., Yokoyama S.;
RT   "Solution structure of the SWIRM domain of human histone demethylase
RT   LSD1.";
RL   Structure 14:457-468(2006).
RN   [42] {ECO:0007744|PDB:2Y48}
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 123-852 IN COMPLEX WITH FAD;
RP   SNAI1 PEPTIDE AND RCOR1, FUNCTION, ACTIVITY REGULATION, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=21300290; DOI=10.1016/j.str.2011.01.001;
RA   Baron R., Binda C., Tortorici M., McCammon J.A., Mattevi A.;
RT   "Molecular mimicry and ligand recognition in binding and catalysis by the
RT   histone demethylase LSD1-CoREST complex.";
RL   Structure 19:212-220(2011).
RN   [43] {ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT, ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV, ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0, ECO:0007744|PDB:3ZN1}
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) IN COMPLEXES WITH FAD; RCOR1; INSM1
RP   PEPTIDE AND SNAI1 PEPTIDE, FUNCTION, ACTIVITY REGULATION, COFACTOR, AND
RP   SUBUNIT.
RX   PubMed=23721412; DOI=10.1021/cb4001926;
RA   Tortorici M., Borrello M.T., Tardugno M., Chiarelli L.R., Pilotto S.,
RA   Ciossani G., Vellore N.A., Bailey S.G., Cowan J., O'Connell M., Crabb S.J.,
RA   Packham G., Mai A., Baron R., Ganesan A., Mattevi A.;
RT   "Protein recognition by short peptide reversible inhibitors of the
RT   chromatin-modifying LSD1/CoREST lysine demethylase.";
RL   ACS Chem. Biol. 8:1677-1682(2013).
RN   [44]
RP   VARIANT CPRF GLY-556.
RX   PubMed=23020937; DOI=10.1016/s0140-6736(12)61480-9;
RA   Rauch A., Wieczorek D., Graf E., Wieland T., Endele S., Schwarzmayr T.,
RA   Albrecht B., Bartholdi D., Beygo J., Di Donato N., Dufke A., Cremer K.,
RA   Hempel M., Horn D., Hoyer J., Joset P., Roepke A., Moog U., Riess A.,
RA   Thiel C.T., Tzschach A., Wiesener A., Wohlleber E., Zweier C., Ekici A.B.,
RA   Zink A.M., Rump A., Meisinger C., Grallert H., Sticht H., Schenck A.,
RA   Engels H., Rappold G., Schroeck E., Wieacker P., Riess O., Meitinger T.,
RA   Reis A., Strom T.M.;
RT   "Range of genetic mutations associated with severe non-syndromic sporadic
RT   intellectual disability: an exome sequencing study.";
RL   Lancet 380:1674-1682(2012).
RN   [45]
RP   VARIANT CPRF HIS-761.
RX   PubMed=24838796; DOI=10.1002/ajmg.a.36450;
RA   Tunovic S., Barkovich J., Sherr E.H., Slavotinek A.M.;
RT   "De novo ANKRD11 and KDM1A gene mutations in a male with features of KBG
RT   syndrome and Kabuki syndrome.";
RL   Am. J. Med. Genet. A 164A:1744-1749(2014).
RN   [46]
RP   VARIANTS CPRF LYS-379; GLY-556 AND HIS-761.
RX   PubMed=26656649; DOI=10.1038/gim.2015.161;
RA   Chong J.X., Yu J.H., Lorentzen P., Park K.M., Jamal S.M., Tabor H.K.,
RA   Rauch A., Saenz M.S., Boltshauser E., Patterson K.E., Nickerson D.A.,
RA   Bamshad M.J.;
RT   "Gene discovery for Mendelian conditions via social networking: de novo
RT   variants in KDM1A cause developmental delay and distinctive facial
RT   features.";
RL   Genet. Med. 18:788-795(2016).
CC   -!- FUNCTION: Histone demethylase that can demethylate both 'Lys-4'
CC       (H3K4me) and 'Lys-9' (H3K9me) of histone H3, thereby acting as a
CC       coactivator or a corepressor, depending on the context
CC       (PubMed:15620353, PubMed:15811342, PubMed:16140033, PubMed:16079794,
CC       PubMed:16079795, PubMed:16223729). Acts by oxidizing the substrate by
CC       FAD to generate the corresponding imine that is subsequently hydrolyzed
CC       (PubMed:15620353, PubMed:15811342, PubMed:16079794, PubMed:21300290).
CC       Acts as a corepressor by mediating demethylation of H3K4me, a specific
CC       tag for epigenetic transcriptional activation. Demethylates both
CC       mono- (H3K4me1) and di-methylated (H3K4me2) H3K4me (PubMed:15620353,
CC       PubMed:20389281, PubMed:21300290, PubMed:23721412). May play a role in
CC       the repression of neuronal genes. Alone, it is unable to demethylate
CC       H3K4me on nucleosomes and requires the presence of RCOR1/CoREST to
CC       achieve such activity (PubMed:16140033, PubMed:16079794,
CC       PubMed:16885027, PubMed:21300290, PubMed:23721412). Also acts as a
CC       coactivator of androgen receptor (AR)-dependent transcription, by being
CC       recruited to AR target genes and mediating demethylation of H3K9me, a
CC       specific tag for epigenetic transcriptional repression. The presence of
CC       PRKCB in AR-containing complexes, which mediates phosphorylation of
CC       'Thr-6' of histone H3 (H3T6ph), a specific tag that prevents
CC       demethylation H3K4me, prevents H3K4me demethylase activity of KDM1A
CC       (PubMed:16079795). Demethylates di-methylated 'Lys-370' of p53/TP53
CC       which prevents interaction of p53/TP53 with TP53BP1 and represses
CC       p53/TP53-mediated transcriptional activation. Demethylates and
CC       stabilizes the DNA methylase DNMT1 (PubMed:29691401). Demethylates
CC       methylated 'Lys-42' and methylated 'Lys-117' of SOX2 (PubMed:29358331).
CC       Required for gastrulation during embryogenesis. Component of a
CC       RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase
CC       (HDAC) recruitment, a number of genes implicated in multilineage blood
CC       cell development. Effector of SNAI1-mediated transcription repression
CC       of E-cadherin/CDH1, CDN7 and KRT8. Required for the maintenance of the
CC       silenced state of the SNAI1 target genes E-cadherin/CDH1 and CDN7
CC       (PubMed:20389281). {ECO:0000269|PubMed:12032298,
CC       ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342,
CC       ECO:0000269|PubMed:16079794, ECO:0000269|PubMed:16079795,
CC       ECO:0000269|PubMed:16140033, ECO:0000269|PubMed:16223729,
CC       ECO:0000269|PubMed:16885027, ECO:0000269|PubMed:16956976,
CC       ECO:0000269|PubMed:17805299, ECO:0000269|PubMed:20228790,
CC       ECO:0000269|PubMed:20389281, ECO:0000269|PubMed:20562920,
CC       ECO:0000269|PubMed:21300290, ECO:0000269|PubMed:23721412,
CC       ECO:0000269|PubMed:29358331, ECO:0000269|PubMed:29691401}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2 A + 2 H2O + N(6),N(6)-dimethyl-L-lysyl(4)-[histone H3] = 2
CC         AH2 + 2 formaldehyde + L-lysyl(4)-[histone H3]; Xref=Rhea:RHEA:60244,
CC         Rhea:RHEA-COMP:15540, Rhea:RHEA-COMP:15547, ChEBI:CHEBI:13193,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:16842, ChEBI:CHEBI:17499,
CC         ChEBI:CHEBI:29969, ChEBI:CHEBI:61976; EC=1.14.99.66;
CC         Evidence={ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342};
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC         Evidence={ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342,
CC         ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
CC         ECO:0000269|PubMed:23721412};
CC   -!- ACTIVITY REGULATION: The N-terminal sequences of INSM1 and SNAI1
CC       compete with histone H3 for the same binding site and thereby inhibit
CC       histone demethylation (in vitro). {ECO:0000269|PubMed:21300290,
CC       ECO:0000269|PubMed:23721412}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3 uM for H3 monomethyl-K4 {ECO:0000269|PubMed:16223729};
CC         KM=4.2 uM for H3 dimethyl-K4 {ECO:0000269|PubMed:16223729};
CC         KM=3.9 uM for H3 monomethyl-K4-monomethyl-K9
CC         {ECO:0000269|PubMed:16223729};
CC         KM=17.5 uM for monomethyl-K4-acetyl-K9 {ECO:0000269|PubMed:16223729};
CC   -!- SUBUNIT: Component of a histone demethylase complex with RCOR1
CC       (PubMed:20389281, PubMed:23721412, PubMed:16885027, PubMed:21300290).
CC       Component of a RCOR/GFI/KDM1A/HDAC complex (PubMed:12032298,
CC       PubMed:11102443). Interacts directly with GFI1 and GFI1B. Interacts
CC       with INSM1 (via N-terminus) (PubMed:23721412). Component of a BHC
CC       histone deacetylase complex that contains HDAC1, HDAC2, HMG20B, KDM1A,
CC       RCOR1 and PHF21A. The BHC complex may also contain ZMYM2, ZNF217,
CC       ZMYM3, GSE1 and GTF2I (PubMed:12493763, PubMed:16140033,
CC       PubMed:16885027). In the complex, RCOR1/CoREST strongly enhances the
CC       demethylase activity and protects it from the proteasome while
CC       PHF21A/BHC80 inhibits the demethylase activity (PubMed:16079794,
CC       PubMed:16956976). Interacts with the androgen receptor (AR)
CC       (PubMed:16079795). Interacts with SNAI1 (via SNAG domain)
CC       (PubMed:20389281, PubMed:20562920, PubMed:21300290, PubMed:23721412).
CC       Interacts (via AOD/Tower domain) with JADE2 (via C-terminus)
CC       (PubMed:25018020). Interacts with ESRRB; co-occupes the core set of
CC       ESRRB targets (By similarity). Interacts with SAMD1 (via WH domain);
CC       the interaction modulates KDM1A function (PubMed:33980486). Interacts
CC       with RBPJ (PubMed:29030483). Interacts with L3MBTL3 (PubMed:29030483).
CC       Interacts with ZMYND8 (PubMed:25593309). {ECO:0000250|UniProtKB:Q6ZQ88,
CC       ECO:0000269|PubMed:11102443, ECO:0000269|PubMed:12032298,
CC       ECO:0000269|PubMed:12493763, ECO:0000269|PubMed:16079794,
CC       ECO:0000269|PubMed:16079795, ECO:0000269|PubMed:16140033,
CC       ECO:0000269|PubMed:16885027, ECO:0000269|PubMed:16956976,
CC       ECO:0000269|PubMed:20389281, ECO:0000269|PubMed:20562920,
CC       ECO:0000269|PubMed:21300290, ECO:0000269|PubMed:23721412,
CC       ECO:0000269|PubMed:25018020, ECO:0000269|PubMed:25593309,
CC       ECO:0000269|PubMed:29030483, ECO:0000269|PubMed:33980486}.
CC   -!- INTERACTION:
CC       O60341; Q9BYF1: ACE2; NbExp=19; IntAct=EBI-710124, EBI-7730807;
CC       O60341; Q99996: AKAP9; NbExp=2; IntAct=EBI-710124, EBI-1048311;
CC       O60341; Q86SG2: ANKRD23; NbExp=3; IntAct=EBI-710124, EBI-5661893;
CC       O60341; Q13490: BIRC2; NbExp=3; IntAct=EBI-710124, EBI-514538;
CC       O60341; Q6P047: C8orf74; NbExp=2; IntAct=EBI-710124, EBI-8466055;
CC       O60341; Q8TC20-4: CAGE1; NbExp=3; IntAct=EBI-710124, EBI-11522698;
CC       O60341; Q9BWT7: CARD10; NbExp=3; IntAct=EBI-710124, EBI-3866279;
CC       O60341; Q49A88-3: CCDC14; NbExp=3; IntAct=EBI-710124, EBI-12105646;
CC       O60341; Q99459: CDC5L; NbExp=3; IntAct=EBI-710124, EBI-374880;
CC       O60341; Q9BXL8: CDCA4; NbExp=2; IntAct=EBI-710124, EBI-1773949;
CC       O60341; Q86XR8-3: CEP57; NbExp=3; IntAct=EBI-710124, EBI-11752486;
CC       O60341; Q8NHQ1: CEP70; NbExp=2; IntAct=EBI-710124, EBI-739624;
CC       O60341; Q8TAP6: CEP76; NbExp=3; IntAct=EBI-710124, EBI-742887;
CC       O60341; Q12873: CHD3; NbExp=4; IntAct=EBI-710124, EBI-523590;
CC       O60341; P38432: COIL; NbExp=3; IntAct=EBI-710124, EBI-945751;
CC       O60341; Q96EY1: DNAJA3; NbExp=2; IntAct=EBI-710124, EBI-356767;
CC       O60341; P26378-2: ELAVL4; NbExp=3; IntAct=EBI-710124, EBI-21603100;
CC       O60341; Q9UPT5-1: EXOC7; NbExp=3; IntAct=EBI-710124, EBI-6251402;
CC       O60341; Q3B820: FAM161A; NbExp=3; IntAct=EBI-710124, EBI-719941;
CC       O60341; Q9H8W3: FAM204A; NbExp=3; IntAct=EBI-710124, EBI-8465160;
CC       O60341; Q8IZU1: FAM9A; NbExp=2; IntAct=EBI-710124, EBI-8468186;
CC       O60341; Q9BQS8: FYCO1; NbExp=2; IntAct=EBI-710124, EBI-2869338;
CC       O60341; O95995: GAS8; NbExp=3; IntAct=EBI-710124, EBI-1052570;
CC       O60341; Q96CN9: GCC1; NbExp=3; IntAct=EBI-710124, EBI-746252;
CC       O60341; Q08379: GOLGA2; NbExp=3; IntAct=EBI-710124, EBI-618309;
CC       O60341; Q9NYA3: GOLGA6A; NbExp=3; IntAct=EBI-710124, EBI-11163335;
CC       O60341; Q8NEC7: GSTCD; NbExp=2; IntAct=EBI-710124, EBI-8469616;
CC       O60341; Q9BX10: GTPBP2; NbExp=2; IntAct=EBI-710124, EBI-6115579;
CC       O60341; Q16695: H3-4; NbExp=2; IntAct=EBI-710124, EBI-358900;
CC       O60341; Q96CS2: HAUS1; NbExp=2; IntAct=EBI-710124, EBI-2514791;
CC       O60341; O15379: HDAC3; NbExp=4; IntAct=EBI-710124, EBI-607682;
CC       O60341; Q9UBX0: HESX1; NbExp=2; IntAct=EBI-710124, EBI-8470369;
CC       O60341; Q9NSC5: HOMER3; NbExp=3; IntAct=EBI-710124, EBI-748420;
CC       O60341; Q16891: IMMT; NbExp=2; IntAct=EBI-710124, EBI-473801;
CC       O60341; O75564-2: JRK; NbExp=3; IntAct=EBI-710124, EBI-17181882;
CC       O60341; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-710124, EBI-14069005;
CC       O60341; Q8TBB5: KLHDC4; NbExp=2; IntAct=EBI-710124, EBI-8472352;
CC       O60341; P19012: KRT15; NbExp=3; IntAct=EBI-710124, EBI-739566;
CC       O60341; Q15323: KRT31; NbExp=3; IntAct=EBI-710124, EBI-948001;
CC       O60341; Q14525: KRT33B; NbExp=4; IntAct=EBI-710124, EBI-1049638;
CC       O60341; Q92764: KRT35; NbExp=3; IntAct=EBI-710124, EBI-1058674;
CC       O60341; Q6A163: KRT39; NbExp=3; IntAct=EBI-710124, EBI-11958242;
CC       O60341; Q6A162: KRT40; NbExp=3; IntAct=EBI-710124, EBI-10171697;
CC       O60341; Q96JB6: LOXL4; NbExp=2; IntAct=EBI-710124, EBI-749562;
CC       O60341; Q9Y250: LZTS1; NbExp=3; IntAct=EBI-710124, EBI-1216080;
CC       O60341; O95983: MBD3; NbExp=4; IntAct=EBI-710124, EBI-1783068;
CC       O60341; P01106: MYC; NbExp=4; IntAct=EBI-710124, EBI-447544;
CC       O60341; Q3BBV0: NBPF1; NbExp=5; IntAct=EBI-710124, EBI-2804530;
CC       O60341; Q7Z6G3-2: NECAB2; NbExp=3; IntAct=EBI-710124, EBI-10172876;
CC       O60341; P35240: NF2; NbExp=4; IntAct=EBI-710124, EBI-1014472;
CC       O60341; Q16236: NFE2L2; NbExp=5; IntAct=EBI-710124, EBI-2007911;
CC       O60341; P46531: NOTCH1; NbExp=8; IntAct=EBI-710124, EBI-636374;
CC       O60341; Q13133: NR1H3; NbExp=2; IntAct=EBI-710124, EBI-781356;
CC       O60341; Q96F24: NRBF2; NbExp=3; IntAct=EBI-710124, EBI-2362014;
CC       O60341; A5D8V7: ODAD3; NbExp=2; IntAct=EBI-710124, EBI-8466445;
CC       O60341; Q8IZS5: OFCC1; NbExp=2; IntAct=EBI-710124, EBI-8477661;
CC       O60341; Q9BYU1: PBX4; NbExp=3; IntAct=EBI-710124, EBI-10302990;
CC       O60341; Q8IZL8: PELP1; NbExp=6; IntAct=EBI-710124, EBI-716449;
CC       O60341; Q99471: PFDN5; NbExp=3; IntAct=EBI-710124, EBI-357275;
CC       O60341; Q5T6S3: PHF19; NbExp=2; IntAct=EBI-710124, EBI-2339674;
CC       O60341; Q03181: PPARD; NbExp=2; IntAct=EBI-710124, EBI-6426768;
CC       O60341; P62191: PSMC1; NbExp=2; IntAct=EBI-710124, EBI-357598;
CC       O60341; Q9NS23: RASSF1; NbExp=2; IntAct=EBI-710124, EBI-367363;
CC       O60341; P50749: RASSF2; NbExp=2; IntAct=EBI-710124, EBI-960081;
CC       O60341; Q86WH2: RASSF3; NbExp=3; IntAct=EBI-710124, EBI-2845202;
CC       O60341; Q06330: RBPJ; NbExp=4; IntAct=EBI-710124, EBI-632552;
CC       O60341; Q9UKL0: RCOR1; NbExp=7; IntAct=EBI-710124, EBI-926563;
CC       O60341; Q8IZ40: RCOR2; NbExp=3; IntAct=EBI-710124, EBI-723853;
CC       O60341; Q9P2K3-2: RCOR3; NbExp=6; IntAct=EBI-710124, EBI-1504830;
CC       O60341; Q96P16-3: RPRD1A; NbExp=3; IntAct=EBI-710124, EBI-12840198;
CC       O60341; Q8N6K7: SAMD3; NbExp=2; IntAct=EBI-710124, EBI-748741;
CC       O60341; Q9UGK8: SERGEF; NbExp=2; IntAct=EBI-710124, EBI-465368;
CC       O60341; Q13435: SF3B2; NbExp=2; IntAct=EBI-710124, EBI-749111;
CC       O60341; O15198: SMAD9; NbExp=2; IntAct=EBI-710124, EBI-748763;
CC       O60341; O95863: SNAI1; NbExp=32; IntAct=EBI-710124, EBI-1045459;
CC       O60341; Q96H20: SNF8; NbExp=2; IntAct=EBI-710124, EBI-747719;
CC       O60341; Q8N0Z3: SPICE1; NbExp=4; IntAct=EBI-710124, EBI-2361917;
CC       O60341; Q96BD6: SPSB1; NbExp=2; IntAct=EBI-710124, EBI-2659201;
CC       O60341; Q8N4C7: STX19; NbExp=2; IntAct=EBI-710124, EBI-8484990;
CC       O60341; Q8N6V9: TEX9; NbExp=4; IntAct=EBI-710124, EBI-746341;
CC       O60341; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-710124, EBI-1105213;
CC       O60341; Q08117-2: TLE5; NbExp=3; IntAct=EBI-710124, EBI-11741437;
CC       O60341; Q2M3C6: TMEM266; NbExp=3; IntAct=EBI-710124, EBI-12163061;
CC       O60341; P45379-11: TNNT2; NbExp=3; IntAct=EBI-710124, EBI-17559309;
CC       O60341; Q05BL1: TP53BP2; NbExp=3; IntAct=EBI-710124, EBI-11952721;
CC       O60341; Q9BUZ4: TRAF4; NbExp=4; IntAct=EBI-710124, EBI-3650647;
CC       O60341; Q5W5X9-3: TTC23; NbExp=3; IntAct=EBI-710124, EBI-9090990;
CC       O60341; Q8TF42: UBASH3B; NbExp=3; IntAct=EBI-710124, EBI-1380492;
CC       O60341; Q9H9H4: VPS37B; NbExp=3; IntAct=EBI-710124, EBI-4400866;
CC       O60341; Q9Y3C0: WASHC3; NbExp=3; IntAct=EBI-710124, EBI-712969;
CC       O60341; O96006: ZBED1; NbExp=4; IntAct=EBI-710124, EBI-740037;
CC       O60341; O15060: ZBTB39; NbExp=3; IntAct=EBI-710124, EBI-9995672;
CC       O60341; Q92618: ZNF516; NbExp=6; IntAct=EBI-710124, EBI-2799490;
CC       O60341-1; O14646: CHD1; NbExp=8; IntAct=EBI-15599570, EBI-1560858;
CC       O60341-1; Q96KQ7: EHMT2; NbExp=2; IntAct=EBI-15599570, EBI-744366;
CC       O60341-1; Q96KQ7-1: EHMT2; NbExp=3; IntAct=EBI-15599570, EBI-15737402;
CC       O60341-1; P05771-1: PRKCB; NbExp=2; IntAct=EBI-15599570, EBI-5774492;
CC       O60341-1; Q9UKL0: RCOR1; NbExp=6; IntAct=EBI-15599570, EBI-926563;
CC       O60341-1; P17542: TAL1; NbExp=5; IntAct=EBI-15599570, EBI-1753878;
CC       O60341-1; P04637: TP53; NbExp=6; IntAct=EBI-15599570, EBI-366083;
CC       O60341-1; P22091: Tal1; Xeno; NbExp=2; IntAct=EBI-15599570, EBI-8006437;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11102443,
CC       ECO:0000269|PubMed:16079795, ECO:0000269|PubMed:20389281,
CC       ECO:0000269|PubMed:33980486}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O60341-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O60341-2; Sequence=VSP_011198, VSP_011199;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:16079795}.
CC   -!- INDUCTION: Down-regulated during neural differentiation in
CC       neuroblastoma cancer. {ECO:0000269|PubMed:25018020}.
CC   -!- DOMAIN: The SWIRM domain may act as an anchor site for a histone tail.
CC       {ECO:0000269|PubMed:16531230}.
CC   -!- PTM: Polyubiquitinated by JADE2; which leads to its proteasomal
CC       degradation. {ECO:0000269|PubMed:25018020}.
CC   -!- DISEASE: Cleft palate, psychomotor retardation, and distinctive facial
CC       features (CPRF) [MIM:616728]: A syndrome characterized by cleft palate,
CC       developmental delay, psychomotor retardation, and facial dysmorphic
CC       features including a prominent forehead, slightly arched eyebrows,
CC       elongated palpebral fissures, a wide nasal bridge, thin lips, and
CC       widely spaced teeth. Cleft palate is a congenital fissure of the soft
CC       and/or hard palate, due to faulty fusion. {ECO:0000269|PubMed:23020937,
CC       ECO:0000269|PubMed:24838796, ECO:0000269|PubMed:26656649}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the flavin monoamine oxidase family.
CC       {ECO:0000305}.
CC   -!- CAUTION: Was previously reported to interact with ASXL1. However, this
CC       publication has been retracted. {ECO:0000305|PubMed:19880879,
CC       ECO:0000305|PubMed:25750265}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA25527.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB011173; BAA25527.1; ALT_INIT; mRNA.
DR   EMBL; AL031428; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC016639; AAH16639.1; -; mRNA.
DR   EMBL; BC025362; AAH25362.1; -; mRNA.
DR   EMBL; BC040194; AAH40194.3; -; mRNA.
DR   EMBL; BC048134; AAH48134.2; -; mRNA.
DR   EMBL; AL833812; CAD38675.2; -; mRNA.
DR   CCDS; CCDS30627.1; -. [O60341-1]
DR   CCDS; CCDS53278.1; -. [O60341-2]
DR   RefSeq; NP_001009999.1; NM_001009999.2. [O60341-2]
DR   RefSeq; NP_055828.2; NM_015013.3. [O60341-1]
DR   PDB; 2COM; NMR; -; A=169-279.
DR   PDB; 2DW4; X-ray; 2.30 A; A=172-831.
DR   PDB; 2EJR; X-ray; 2.70 A; A=172-833.
DR   PDB; 2H94; X-ray; 2.90 A; A=172-835.
DR   PDB; 2HKO; X-ray; 2.80 A; A=172-835.
DR   PDB; 2IW5; X-ray; 2.57 A; A=171-836.
DR   PDB; 2L3D; NMR; -; A=174-273.
DR   PDB; 2UXN; X-ray; 2.72 A; A=171-836.
DR   PDB; 2UXX; X-ray; 2.74 A; A=171-836.
DR   PDB; 2V1D; X-ray; 3.10 A; A=123-852.
DR   PDB; 2X0L; X-ray; 3.00 A; A=123-852.
DR   PDB; 2XAF; X-ray; 3.25 A; A=1-852.
DR   PDB; 2XAG; X-ray; 3.10 A; A=1-852.
DR   PDB; 2XAH; X-ray; 3.10 A; A=1-852.
DR   PDB; 2XAJ; X-ray; 3.30 A; A=1-852.
DR   PDB; 2XAQ; X-ray; 3.20 A; A=1-852.
DR   PDB; 2XAS; X-ray; 3.20 A; A=1-852.
DR   PDB; 2Y48; X-ray; 3.00 A; A=123-852.
DR   PDB; 2Z3Y; X-ray; 2.25 A; A=172-833.
DR   PDB; 2Z5U; X-ray; 2.25 A; A=172-833.
DR   PDB; 3ABT; X-ray; 3.20 A; A=172-833.
DR   PDB; 3ABU; X-ray; 3.10 A; A=172-833.
DR   PDB; 3ZMS; X-ray; 2.96 A; A=1-852.
DR   PDB; 3ZMT; X-ray; 3.10 A; A=1-852.
DR   PDB; 3ZMU; X-ray; 3.20 A; A=1-852.
DR   PDB; 3ZMV; X-ray; 3.00 A; A=1-852.
DR   PDB; 3ZMZ; X-ray; 3.00 A; A=1-852.
DR   PDB; 3ZN0; X-ray; 2.80 A; A=1-852.
DR   PDB; 3ZN1; X-ray; 3.10 A; A=1-852.
DR   PDB; 4BAY; X-ray; 3.10 A; A=172-852.
DR   PDB; 4CZZ; X-ray; 3.00 A; A=1-852.
DR   PDB; 4KUM; X-ray; 3.05 A; A=171-836.
DR   PDB; 4UV8; X-ray; 2.80 A; A=1-852.
DR   PDB; 4UV9; X-ray; 3.00 A; A=1-852.
DR   PDB; 4UVA; X-ray; 2.90 A; A=1-852.
DR   PDB; 4UVB; X-ray; 2.80 A; A=1-852.
DR   PDB; 4UVC; X-ray; 3.10 A; A=1-852.
DR   PDB; 4UXN; X-ray; 2.85 A; A=1-852.
DR   PDB; 4XBF; X-ray; 2.80 A; A=171-836.
DR   PDB; 5AFW; X-ray; 1.60 A; B=108-119.
DR   PDB; 5H6Q; X-ray; 2.53 A; A=172-833.
DR   PDB; 5H6R; X-ray; 2.60 A; A=172-833.
DR   PDB; 5IT3; X-ray; 1.40 A; A/B=183-267.
DR   PDB; 5L3B; X-ray; 3.30 A; A=1-852.
DR   PDB; 5L3C; X-ray; 3.31 A; A=1-852.
DR   PDB; 5L3D; X-ray; 2.60 A; A=1-852.
DR   PDB; 5L3E; X-ray; 2.80 A; A=123-852.
DR   PDB; 5L3F; X-ray; 3.50 A; A=123-852.
DR   PDB; 5L3G; X-ray; 3.10 A; A=123-852.
DR   PDB; 5LBQ; X-ray; 3.30 A; A=123-852.
DR   PDB; 5LGN; X-ray; 3.20 A; A=172-836.
DR   PDB; 5LGT; X-ray; 3.00 A; A=123-852.
DR   PDB; 5LGU; X-ray; 3.20 A; A=123-852.
DR   PDB; 5LHG; X-ray; 3.34 A; A=1-852.
DR   PDB; 5LHH; X-ray; 3.05 A; A=1-852.
DR   PDB; 5LHI; X-ray; 3.40 A; A=1-852.
DR   PDB; 5X60; X-ray; 2.69 A; A=172-833.
DR   PDB; 5YJB; X-ray; 2.96 A; A=172-833.
DR   PDB; 6E1F; X-ray; 1.16 A; A/B/C/D=183-267.
DR   PDB; 6K3E; X-ray; 2.87 A; A=172-833.
DR   PDB; 6KGK; X-ray; 2.70 A; A=172-833.
DR   PDB; 6KGL; X-ray; 2.70 A; A=172-833.
DR   PDB; 6KGM; X-ray; 2.62 A; A=172-833.
DR   PDB; 6KGN; X-ray; 2.62 A; A=172-833.
DR   PDB; 6KGO; X-ray; 2.25 A; A=172-833.
DR   PDB; 6KGP; X-ray; 2.25 A; A=172-833.
DR   PDB; 6KGQ; X-ray; 2.32 A; A=172-833.
DR   PDB; 6KGR; X-ray; 2.32 A; A=172-833.
DR   PDB; 6NQM; X-ray; 2.90 A; A=173-830.
DR   PDB; 6NQU; X-ray; 2.70 A; A=173-830.
DR   PDB; 6NR5; X-ray; 2.90 A; A=173-830.
DR   PDB; 6S35; X-ray; 3.10 A; A=172-833.
DR   PDB; 6TE1; X-ray; 3.11 A; A=1-852.
DR   PDB; 6TUY; X-ray; 2.60 A; A=1-852.
DR   PDB; 6VYP; X-ray; 4.99 A; K/M/k/m=171-852.
DR   PDB; 6W4K; X-ray; 2.93 A; A=174-832.
DR   PDB; 6WC6; X-ray; 3.10 A; A=171-836, C=137-151.
DR   PDB; 7CDC; X-ray; 2.64 A; A=172-833.
DR   PDB; 7CDD; X-ray; 2.76 A; A=172-833.
DR   PDB; 7CDE; X-ray; 2.68 A; A=172-833.
DR   PDB; 7CDF; X-ray; 2.68 A; A=172-833.
DR   PDB; 7CDG; X-ray; 2.80 A; A=172-833.
DR   PDB; 7E0G; X-ray; 2.25 A; A=172-833.
DR   PDB; 7JJL; X-ray; 2.60 A; B=104-129.
DR   PDB; 7JJM; X-ray; 2.06 A; A=104-129.
DR   PDB; 7JK7; X-ray; 1.96 A; A=104-129.
DR   PDB; 7VQS; X-ray; 2.94 A; A=172-833.
DR   PDB; 7VQT; X-ray; 2.91 A; A=172-833.
DR   PDB; 7VQU; X-ray; 2.94 A; A=172-833.
DR   PDB; 7W3L; X-ray; 2.51 A; A=172-833.
DR   PDB; 7XW8; X-ray; 2.28 A; A=172-833.
DR   PDB; 7ZRY; X-ray; 2.70 A; A=1-852.
DR   PDBsum; 2COM; -.
DR   PDBsum; 2DW4; -.
DR   PDBsum; 2EJR; -.
DR   PDBsum; 2H94; -.
DR   PDBsum; 2HKO; -.
DR   PDBsum; 2IW5; -.
DR   PDBsum; 2L3D; -.
DR   PDBsum; 2UXN; -.
DR   PDBsum; 2UXX; -.
DR   PDBsum; 2V1D; -.
DR   PDBsum; 2X0L; -.
DR   PDBsum; 2XAF; -.
DR   PDBsum; 2XAG; -.
DR   PDBsum; 2XAH; -.
DR   PDBsum; 2XAJ; -.
DR   PDBsum; 2XAQ; -.
DR   PDBsum; 2XAS; -.
DR   PDBsum; 2Y48; -.
DR   PDBsum; 2Z3Y; -.
DR   PDBsum; 2Z5U; -.
DR   PDBsum; 3ABT; -.
DR   PDBsum; 3ABU; -.
DR   PDBsum; 3ZMS; -.
DR   PDBsum; 3ZMT; -.
DR   PDBsum; 3ZMU; -.
DR   PDBsum; 3ZMV; -.
DR   PDBsum; 3ZMZ; -.
DR   PDBsum; 3ZN0; -.
DR   PDBsum; 3ZN1; -.
DR   PDBsum; 4BAY; -.
DR   PDBsum; 4CZZ; -.
DR   PDBsum; 4KUM; -.
DR   PDBsum; 4UV8; -.
DR   PDBsum; 4UV9; -.
DR   PDBsum; 4UVA; -.
DR   PDBsum; 4UVB; -.
DR   PDBsum; 4UVC; -.
DR   PDBsum; 4UXN; -.
DR   PDBsum; 4XBF; -.
DR   PDBsum; 5AFW; -.
DR   PDBsum; 5H6Q; -.
DR   PDBsum; 5H6R; -.
DR   PDBsum; 5IT3; -.
DR   PDBsum; 5L3B; -.
DR   PDBsum; 5L3C; -.
DR   PDBsum; 5L3D; -.
DR   PDBsum; 5L3E; -.
DR   PDBsum; 5L3F; -.
DR   PDBsum; 5L3G; -.
DR   PDBsum; 5LBQ; -.
DR   PDBsum; 5LGN; -.
DR   PDBsum; 5LGT; -.
DR   PDBsum; 5LGU; -.
DR   PDBsum; 5LHG; -.
DR   PDBsum; 5LHH; -.
DR   PDBsum; 5LHI; -.
DR   PDBsum; 5X60; -.
DR   PDBsum; 5YJB; -.
DR   PDBsum; 6E1F; -.
DR   PDBsum; 6K3E; -.
DR   PDBsum; 6KGK; -.
DR   PDBsum; 6KGL; -.
DR   PDBsum; 6KGM; -.
DR   PDBsum; 6KGN; -.
DR   PDBsum; 6KGO; -.
DR   PDBsum; 6KGP; -.
DR   PDBsum; 6KGQ; -.
DR   PDBsum; 6KGR; -.
DR   PDBsum; 6NQM; -.
DR   PDBsum; 6NQU; -.
DR   PDBsum; 6NR5; -.
DR   PDBsum; 6S35; -.
DR   PDBsum; 6TE1; -.
DR   PDBsum; 6TUY; -.
DR   PDBsum; 6VYP; -.
DR   PDBsum; 6W4K; -.
DR   PDBsum; 6WC6; -.
DR   PDBsum; 7CDC; -.
DR   PDBsum; 7CDD; -.
DR   PDBsum; 7CDE; -.
DR   PDBsum; 7CDF; -.
DR   PDBsum; 7CDG; -.
DR   PDBsum; 7E0G; -.
DR   PDBsum; 7JJL; -.
DR   PDBsum; 7JJM; -.
DR   PDBsum; 7JK7; -.
DR   PDBsum; 7VQS; -.
DR   PDBsum; 7VQT; -.
DR   PDBsum; 7VQU; -.
DR   PDBsum; 7W3L; -.
DR   PDBsum; 7XW8; -.
DR   PDBsum; 7ZRY; -.
DR   AlphaFoldDB; O60341; -.
DR   BMRB; O60341; -.
DR   SASBDB; O60341; -.
DR   SMR; O60341; -.
DR   BioGRID; 116667; 575.
DR   CORUM; O60341; -.
DR   DIP; DIP-34641N; -.
DR   IntAct; O60341; 320.
DR   MINT; O60341; -.
DR   STRING; 9606.ENSP00000383042; -.
DR   BindingDB; O60341; -.
DR   ChEMBL; CHEMBL6136; -.
DR   DrugBank; DB16446; Vafidemstat.
DR   DrugCentral; O60341; -.
DR   GuidetoPHARMACOLOGY; 2669; -.
DR   MoonDB; O60341; Predicted.
DR   GlyGen; O60341; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O60341; -.
DR   MetOSite; O60341; -.
DR   PhosphoSitePlus; O60341; -.
DR   SwissPalm; O60341; -.
DR   BioMuta; KDM1A; -.
DR   EPD; O60341; -.
DR   jPOST; O60341; -.
DR   MassIVE; O60341; -.
DR   MaxQB; O60341; -.
DR   PaxDb; O60341; -.
DR   PeptideAtlas; O60341; -.
DR   ProteomicsDB; 49364; -. [O60341-1]
DR   ProteomicsDB; 49365; -. [O60341-2]
DR   Antibodypedia; 3136; 765 antibodies from 47 providers.
DR   DNASU; 23028; -.
DR   Ensembl; ENST00000356634.7; ENSP00000349049.3; ENSG00000004487.18. [O60341-1]
DR   Ensembl; ENST00000400181.9; ENSP00000383042.5; ENSG00000004487.18. [O60341-2]
DR   GeneID; 23028; -.
DR   KEGG; hsa:23028; -.
DR   MANE-Select; ENST00000400181.9; ENSP00000383042.5; NM_001009999.3; NP_001009999.1. [O60341-2]
DR   UCSC; uc001bgi.3; human. [O60341-1]
DR   AGR; HGNC:29079; -.
DR   CTD; 23028; -.
DR   DisGeNET; 23028; -.
DR   GeneCards; KDM1A; -.
DR   HGNC; HGNC:29079; KDM1A.
DR   HPA; ENSG00000004487; Low tissue specificity.
DR   MalaCards; KDM1A; -.
DR   MIM; 609132; gene.
DR   MIM; 616728; phenotype.
DR   neXtProt; NX_O60341; -.
DR   OpenTargets; ENSG00000004487; -.
DR   Orphanet; 477993; Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome.
DR   PharmGKB; PA165751392; -.
DR   VEuPathDB; HostDB:ENSG00000004487; -.
DR   eggNOG; KOG0029; Eukaryota.
DR   eggNOG; KOG0685; Eukaryota.
DR   GeneTree; ENSGT00940000157193; -.
DR   HOGENOM; CLU_004498_5_1_1; -.
DR   InParanoid; O60341; -.
DR   OMA; SSRGEMF; -.
DR   OrthoDB; 5402444at2759; -.
DR   PhylomeDB; O60341; -.
DR   TreeFam; TF312972; -.
DR   BioCyc; MetaCyc:ENSG00000004487-MON; -.
DR   BRENDA; 1.14.11.65; 2681.
DR   BRENDA; 1.14.11.66; 2681.
DR   BRENDA; 1.14.11.67; 2681.
DR   BRENDA; 1.14.99.66; 2681.
DR   PathwayCommons; O60341; -.
DR   Reactome; R-HSA-3214815; HDACs deacetylate histones.
DR   Reactome; R-HSA-3214842; HDMs demethylate histones.
DR   Reactome; R-HSA-5625886; Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3.
DR   Reactome; R-HSA-8943724; Regulation of PTEN gene transcription.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9029569; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux.
DR   Reactome; R-HSA-9679191; Potential therapeutics for SARS.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SABIO-RK; O60341; -.
DR   SignaLink; O60341; -.
DR   SIGNOR; O60341; -.
DR   BioGRID-ORCS; 23028; 121 hits in 1204 CRISPR screens.
DR   ChiTaRS; KDM1A; human.
DR   EvolutionaryTrace; O60341; -.
DR   GenomeRNAi; 23028; -.
DR   Pharos; O60341; Tchem.
DR   PRO; PR:O60341; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O60341; protein.
DR   Bgee; ENSG00000004487; Expressed in ganglionic eminence and 208 other tissues.
DR   ExpressionAtlas; O60341; baseline and differential.
DR   Genevisible; O60341; HS.
DR   GO; GO:0000785; C:chromatin; IDA:BHF-UCL.
DR   GO; GO:0000781; C:chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:1990391; C:DNA repair complex; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0005667; C:transcription regulator complex; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0032451; F:demethylase activity; IMP:BHF-UCL.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IDA:BHF-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0140682; F:FAD-dependent H3K4me/H3K4me3 demethylase activity; IDA:UniProtKB.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IDA:UniProtKB.
DR   GO; GO:0032452; F:histone demethylase activity; IDA:BHF-UCL.
DR   GO; GO:0032453; F:histone H3K4 demethylase activity; IDA:UniProtKB.
DR   GO; GO:0032454; F:histone H3K9 demethylase activity; IDA:UniProtKB.
DR   GO; GO:0043426; F:MRF binding; IDA:BHF-UCL.
DR   GO; GO:0050681; F:nuclear androgen receptor binding; IDA:UniProtKB.
DR   GO; GO:0030374; F:nuclear receptor coactivator activity; IMP:UniProtKB.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; IPI:BHF-UCL.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISS:BHF-UCL.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISS:ARUK-UCL.
DR   GO; GO:0061752; F:telomeric repeat-containing RNA binding; IDA:BHF-UCL.
DR   GO; GO:0000380; P:alternative mRNA splicing, via spliceosome; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:0071480; P:cellular response to gamma radiation; IMP:MGI.
DR   GO; GO:0034644; P:cellular response to UV; IDA:MGI.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0140861; P:DNA repair-dependent chromatin remodeling; IDA:MGI.
DR   GO; GO:0046098; P:guanine metabolic process; IEA:Ensembl.
DR   GO; GO:0034720; P:histone H3-K4 demethylation; IEA:InterPro.
DR   GO; GO:0055001; P:muscle cell development; ISS:BHF-UCL.
DR   GO; GO:0043392; P:negative regulation of DNA binding; IC:BHF-UCL.
DR   GO; GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; IMP:BHF-UCL.
DR   GO; GO:0043433; P:negative regulation of DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:BHF-UCL.
DR   GO; GO:0051572; P:negative regulation of histone H3-K4 methylation; ISS:ARUK-UCL.
DR   GO; GO:0051573; P:negative regulation of histone H3-K9 methylation; ISS:ARUK-UCL.
DR   GO; GO:1902166; P:negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IMP:BHF-UCL.
DR   GO; GO:0032091; P:negative regulation of protein binding; IMP:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0042551; P:neuron maturation; IEA:Ensembl.
DR   GO; GO:0045793; P:positive regulation of cell size; IEA:Ensembl.
DR   GO; GO:0035563; P:positive regulation of chromatin binding; IEA:Ensembl.
DR   GO; GO:0120162; P:positive regulation of cold-induced thermogenesis; ISS:YuBioLab.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; ISS:ARUK-UCL.
DR   GO; GO:0002052; P:positive regulation of neuroblast proliferation; IMP:BHF-UCL.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IMP:MGI.
DR   GO; GO:2000648; P:positive regulation of stem cell proliferation; ISS:ARUK-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0006482; P:protein demethylation; IMP:BHF-UCL.
DR   GO; GO:0060765; P:regulation of androgen receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0090308; P:regulation of DNA methylation-dependent heterochromatin formation; IDA:UniProtKB.
DR   GO; GO:0010569; P:regulation of double-strand break repair via homologous recombination; IMP:MGI.
DR   GO; GO:0032880; P:regulation of protein localization; IMP:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0060992; P:response to fungicide; IEA:Ensembl.
DR   Gene3D; 3.90.660.10; -; 1.
DR   Gene3D; 1.10.287.80; ATP synthase, gamma subunit, helix hairpin domain; 1.
DR   Gene3D; 3.50.50.60; FAD/NAD(P)-binding domain; 2.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   IDEAL; IID00009; -.
DR   InterPro; IPR002937; Amino_oxidase.
DR   InterPro; IPR036188; FAD/NAD-bd_sf.
DR   InterPro; IPR017366; Hist_Lys-spec_deMease.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR007526; SWIRM.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   PANTHER; PTHR10742; FLAVIN MONOAMINE OXIDASE; 1.
DR   PANTHER; PTHR10742:SF386; LYSINE-SPECIFIC HISTONE DEMETHYLASE 1A; 1.
DR   Pfam; PF01593; Amino_oxidase; 1.
DR   Pfam; PF04433; SWIRM; 1.
DR   PIRSF; PIRSF038051; Histone_Lys-demethylase; 1.
DR   SUPFAM; SSF54373; FAD-linked reductases, C-terminal domain; 1.
DR   SUPFAM; SSF51905; FAD/NAD(P)-binding domain; 1.
DR   SUPFAM; SSF46689; Homeodomain-like; 1.
DR   PROSITE; PS50934; SWIRM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromatin regulator; Coiled coil;
KW   Developmental protein; Direct protein sequencing; Disease variant; FAD;
KW   Flavoprotein; Isopeptide bond; Nucleus; Oxidoreductase; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..852
FT                   /note="Lysine-specific histone demethylase 1A"
FT                   /id="PRO_0000099881"
FT   DOMAIN          174..273
FT                   /note="SWIRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00247"
FT   REGION          1..176
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          300..852
FT                   /note="Demethylase activity"
FT   COILED          110..151
FT                   /evidence="ECO:0000255"
FT   COILED          428..514
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        105..151
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         289
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   BINDING         308
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   BINDING         310
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   BINDING         316
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   BINDING         332..333
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   BINDING         801
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   BINDING         810..811
FT                   /ligand="FAD"
FT                   /ligand_id="ChEBI:CHEBI:57692"
FT                   /evidence="ECO:0000269|PubMed:16885027,
FT                   ECO:0000269|PubMed:16956976, ECO:0000269|PubMed:21300290,
FT                   ECO:0000269|PubMed:23721412, ECO:0007744|PDB:2DW4,
FT                   ECO:0007744|PDB:2H94, ECO:0007744|PDB:2HKO,
FT                   ECO:0007744|PDB:2IW5, ECO:0007744|PDB:2V1D,
FT                   ECO:0007744|PDB:2X0L, ECO:0007744|PDB:2XAF,
FT                   ECO:0007744|PDB:2XAG, ECO:0007744|PDB:2XAH,
FT                   ECO:0007744|PDB:2XAJ, ECO:0007744|PDB:2XAQ,
FT                   ECO:0007744|PDB:2XAS, ECO:0007744|PDB:2Y48,
FT                   ECO:0007744|PDB:3ZMS, ECO:0007744|PDB:3ZMT,
FT                   ECO:0007744|PDB:3ZMU, ECO:0007744|PDB:3ZMV,
FT                   ECO:0007744|PDB:3ZMZ, ECO:0007744|PDB:3ZN0,
FT                   ECO:0007744|PDB:3ZN1"
FT   MOD_RES         59
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         104
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332"
FT   MOD_RES         126
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         131
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         135
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         137
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         166
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         611
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         849
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231"
FT   CROSSLNK        442
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        469
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   CROSSLNK        503
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000305|PubMed:25018020"
FT   VAR_SEQ         173
FT                   /note="G -> GQAGGLQDDSSGGYGDGQASG (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011198"
FT   VAR_SEQ         369
FT                   /note="A -> ADTVK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011199"
FT   VARIANT         379
FT                   /note="E -> K (in CPRF; dbSNP:rs864309715)"
FT                   /evidence="ECO:0000269|PubMed:26656649"
FT                   /id="VAR_076366"
FT   VARIANT         556
FT                   /note="D -> G (in CPRF; dbSNP:rs864309716)"
FT                   /evidence="ECO:0000269|PubMed:23020937,
FT                   ECO:0000269|PubMed:26656649"
FT                   /id="VAR_076367"
FT   VARIANT         761
FT                   /note="Y -> H (in CPRF; dbSNP:rs864309714)"
FT                   /evidence="ECO:0000269|PubMed:24838796,
FT                   ECO:0000269|PubMed:26656649"
FT                   /id="VAR_076368"
FT   MUTAGEN         503
FT                   /note="K->R: Loss of polyubiquitination."
FT                   /evidence="ECO:0000269|PubMed:25018020"
FT   MUTAGEN         535
FT                   /note="N->A: Strongly reduces demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:16956976"
FT   MUTAGEN         564
FT                   /note="H->A: Strongly reduces demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:16956976"
FT   MUTAGEN         661
FT                   /note="K->A: Abolishes histone demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:16079794"
FT   MUTAGEN         761
FT                   /note="Y->A: Strongly reduces demethylase activity."
FT                   /evidence="ECO:0000269|PubMed:16956976"
FT   CONFLICT        78
FT                   /note="P -> Q (in Ref. 3; AAH40194)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        405
FT                   /note="P -> H (in Ref. 3; AAH48134)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        669
FT                   /note="V -> A (in Ref. 4; CAD38675)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        814
FT                   /note="A -> V (in Ref. 3; AAH16639)"
FT                   /evidence="ECO:0000305"
FT   HELIX           138..150
FT                   /evidence="ECO:0007829|PDB:6WC6"
FT   HELIX           173..180
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          181..183
FT                   /evidence="ECO:0007829|PDB:2COM"
FT   STRAND          185..187
FT                   /evidence="ECO:0007829|PDB:2HKO"
FT   HELIX           190..195
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   HELIX           197..200
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   HELIX           204..223
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   HELIX           231..236
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   HELIX           242..244
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   HELIX           246..258
FT                   /evidence="ECO:0007829|PDB:6E1F"
FT   STRAND          261..263
FT                   /evidence="ECO:0007829|PDB:5IT3"
FT   STRAND          265..267
FT                   /evidence="ECO:0007829|PDB:2COM"
FT   STRAND          280..284
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           288..299
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          303..307
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          309..314
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          319..322
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          325..330
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          333..335
FT                   /evidence="ECO:0007829|PDB:6NQU"
FT   HELIX           341..349
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          353..355
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          362..364
FT                   /evidence="ECO:0007829|PDB:6KGM"
FT   STRAND          367..369
FT                   /evidence="ECO:0007829|PDB:5LHH"
FT   HELIX           372..393
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            394..396
FT                   /evidence="ECO:0007829|PDB:2HKO"
FT   STRAND          400..405
FT                   /evidence="ECO:0007829|PDB:5H6Q"
FT   HELIX           408..456
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            457..461
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           476..487
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            488..490
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           491..497
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           499..511
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          518..521
FT                   /evidence="ECO:0007829|PDB:7VQT"
FT   HELIX           523..539
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           544..546
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            549..555
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           556..558
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          565..567
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           573..578
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            579..581
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          583..585
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          588..596
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          599..608
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          613..623
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           627..631
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          636..641
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           645..653
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          654..656
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          660..665
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          676..680
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          683..685
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            686..689
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          690..695
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          698..707
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           710..715
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           720..735
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           737..739
FT                   /evidence="ECO:0007829|PDB:6KGO"
FT   STRAND          744..748
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            751..753
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   TURN            755..757
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          758..760
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          765..767
FT                   /evidence="ECO:0007829|PDB:6NQM"
FT   HELIX           771..777
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          785..788
FT                   /evidence="ECO:0007829|PDB:6S35"
FT   STRAND          796..798
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           801..803
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   STRAND          805..807
FT                   /evidence="ECO:0007829|PDB:5H6R"
FT   HELIX           811..829
FT                   /evidence="ECO:0007829|PDB:2Z3Y"
FT   HELIX           833..835
FT                   /evidence="ECO:0007829|PDB:5L3D"
SQ   SEQUENCE   852 AA;  92903 MW;  A61CEDE51E4E0C1D CRC64;
     MLSGKKAAAA AAAAAAAATG TEAGPGTAGG SENGSEVAAQ PAGLSGPAEV GPGAVGERTP
     RKKEPPRASP PGGLAEPPGS AGPQAGPTVV PGSATPMETG IAETPEGRRT SRRKRAKVEY
     REMDESLANL SEDEYYSEEE RNAKAEKEKK LPPPPPQAPP EEENESEPEE PSGVEGAAFQ
     SRLPHDRMTS QEAACFPDII SGPQQTQKVF LFIRNRTLQL WLDNPKIQLT FEATLQQLEA
     PYNSDTVLVH RVHSYLERHG LINFGIYKRI KPLPTKKTGK VIIIGSGVSG LAAARQLQSF
     GMDVTLLEAR DRVGGRVATF RKGNYVADLG AMVVTGLGGN PMAVVSKQVN MELAKIKQKC
     PLYEANGQAV PKEKDEMVEQ EFNRLLEATS YLSHQLDFNV LNNKPVSLGQ ALEVVIQLQE
     KHVKDEQIEH WKKIVKTQEE LKELLNKMVN LKEKIKELHQ QYKEASEVKP PRDITAEFLV
     KSKHRDLTAL CKEYDELAET QGKLEEKLQE LEANPPSDVY LSSRDRQILD WHFANLEFAN
     ATPLSTLSLK HWDQDDDFEF TGSHLTVRNG YSCVPVALAE GLDIKLNTAV RQVRYTASGC
     EVIAVNTRST SQTFIYKCDA VLCTLPLGVL KQQPPAVQFV PPLPEWKTSA VQRMGFGNLN
     KVVLCFDRVF WDPSVNLFGH VGSTTASRGE LFLFWNLYKA PILLALVAGE AAGIMENISD
     DVIVGRCLAI LKGIFGSSAV PQPKETVVSR WRADPWARGS YSYVAAGSSG NDYDLMAQPI
     TPGPSIPGAP QPIPRLFFAG EHTIRNYPAT VHGALLSGLR EAGRIADQFL GAMYTLPRQA
     TPGVPAQQSP SM
//
